clevidipine has been researched along with doxazosin in 3 studies
Studies (clevidipine) | Trials (clevidipine) | Recent Studies (post-2010) (clevidipine) | Studies (doxazosin) | Trials (doxazosin) | Recent Studies (post-2010) (doxazosin) |
---|---|---|---|---|---|
127 | 19 | 62 | 1,372 | 439 | 283 |
Protein | Taxonomy | clevidipine (IC50) | doxazosin (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.544 | |
Interstitial collagenase | Homo sapiens (human) | 5.749 | |
Beta-2 adrenergic receptor | Homo sapiens (human) | 2.748 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 2.2155 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0034 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.544 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 2.688 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.368 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0007 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.188 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.4022 | |
Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | 2.2155 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Arcas Bellas, JJ; López Pérez, V; Mesa Ruiz, JL; Tebar Cuesta, MY | 1 |
1 review(s) available for clevidipine and doxazosin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for clevidipine and doxazosin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Management of hypertensive crisis with clevidipine in the perioperative setting of a critically ill patient, non-responder to high doses of nitroglycerin, labelatol, urapidil, doxazosin and furosemide.
Topics: Critical Illness; Doxazosin; Furosemide; Humans; Nitroglycerin; Piperazines; Pyridines | 2021 |